Dr. Gary Hammer
Endocrine Oncology Research.
Gary D. Hammer, M.D., Ph.D. serves as the director of the Endocrine Oncology Program in the Comprehensive Cancer Center. The program is uniquely recognized as an international center of excellence for the treatment of adrenal cancer. Research conducted in Dr. Hammer's laboratory has led to the development of new national and international therapeutic trials with biological-based therapies for adrenal cancer that target the molecular defects in cancer stem cells while sparing normal tissue.
Learn more about Adrenal Cancer and the Endocrine Oncology Clinic at the U-M Comprehensive Cancer Center.